Patent reform bill reported to House

Share this article:
The House Judiciary Committee voted before the summer congressional recess to approve and send to the House a bill observers said would overhaul the US patent system by weeding out bad patents and restraining excessive litigation over patents. The measure continues to be opposed by drug and biotech firms.

The bill reportedly would give parties more leeway to question patent validity and would limit damage awards in infringement cases.

“Past attempts at achieving comprehensive patent reform have met with stiff resistance,” said bill chief sponsor Rep. Howard Berman (D-CA).  

Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.